Descripción del título
Bioindustry ethics / David ...
This book is the first systematic, detailed treatment of the approaches to ethical issues taken by biotech and pharmaceutical companies. The application of genetic/genomic technologies raises a whole spectrum of ethical questions affecting global health that must be addressed. Topics covered in this comprehensive survey include considerations for bioprospecting in transgenics, genomics, drug discovery, and nutrigenomics, as well as how to improve stakeholder relations, design ethical clinical trials, avoid conflicts of interest, and establish ethics advisory boards. The expert authors represent multiple disciplines including law, medicine, bioinformatics, pharmaceutics, business, and ethics
Monografía
monografia Rebiun39089956 https://catalogo.rebiun.org/rebiun/record/Rebiun39089956 m o d cr cn||||||||| 070806s2005 ne ob 001 0 eng d 154363149 441784716 505077954 648300386 823826885 823896265 824088426 824134856 961641957 962622076 1034924227 9780123693709 0123693705 9780080492513 electronic bk.) 0080492517 electronic bk.) 1281005339 9781281005335 AU@ 000048129864 CHNEW 001006364 DEBBG BV042305493 DEBBG BV043044767 DEBSZ 367766051 DEBSZ 422202304 NZ1 12434928 NZ1 14540264 112794:112883 Elsevier Science & Technology http://www.sciencedirect.com OPELS eng pn OPELS OCLCQ N$T YDXCP MERUC UBY E7B IDEBK OCLCQ NLGGC OCLCQ OCLCF AZK LOA OCLCO OCLCA AGLDB COCUF OCLCO MOR PIFAG OCLCQ CASUM OCLCO OCLCA OCL WRM VNS OCLCO D6H OCLCO VTS OCLCO CHVBK CRU OCLCA OCLCQ OCLCO VT2 OCLCQ WYU OCLCA STF OCLCO LEAUB OCLCO M8D OCLCO OCLCA S2H OCLCO OCLCQ OCLCO INARC OCLCO OCLCQ OCL OCLCO OCLCL EZC U3G OCLCO UKKRT BUS 008000 bisacsh HPGM bicssc 174/.96606 22 Bioindustry ethics David L. Finegold [and others] Amsterdam Boston Elsevier Academic Press 2005 Amsterdam Boston Amsterdam Boston Elsevier Academic Press 1 online resource (xi, 368 pages) 1 online resource (xi, 368 pages) Text txt rdacontent computer c rdamedia online resource cr rdacarrier Includes index Includes bibliographical references and index Preface -- Introduction -- Leadership -- Starting Right -- Ethics in an Emerging Field -- Getting Advice -- Self-Assessment -- Endnotes This book is the first systematic, detailed treatment of the approaches to ethical issues taken by biotech and pharmaceutical companies. The application of genetic/genomic technologies raises a whole spectrum of ethical questions affecting global health that must be addressed. Topics covered in this comprehensive survey include considerations for bioprospecting in transgenics, genomics, drug discovery, and nutrigenomics, as well as how to improve stakeholder relations, design ethical clinical trials, avoid conflicts of interest, and establish ethics advisory boards. The expert authors represent multiple disciplines including law, medicine, bioinformatics, pharmaceutics, business, and ethics Biotechnology industries- Moral and ethical aspects- Case studies Pharmaceutical industry- Moral and ethical aspects- Case studies Business ethics- Moral and ethical aspects- Case studies Bioethics Business ethics- Case studies Bioethics Biotechnology- ethics Drug Industry- ethics Ethics, Business Bio-industries- Aspect moral- Études de cas Industrie pharmaceutique- Aspect moral- Études de cas Morale des affaires- Études de cas Morale des affaires- Aspect moral- Études de cas Bioéthique BUSINESS & ECONOMICS- Business Ethics. Business ethics. Bioethics. Biotechnology industries- Moral and ethical aspects. Pharmaceutical industry- Moral and ethical aspects. Case Reports dissertations. Case studies. Case studies. Academic theses. Études de cas. Thèses et écrits académiques. Finegold, David Print version Bioindustry ethics. Amsterdam ; Boston : Elsevier Academic Press, 2005 0123693705 9780123693709 (DLC) 2005040638 (OCoLC)57751490